Literature DB >> 26202505

Value of shear wave velocity measurements for the risk assessment of hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease : HCC risk assessment by VTTQ.

Masaaki Takamura1, Tsutomu Kanefuji1, Takeshi Suda2, Takeshi Yokoo1, Hiroteru Kamimura1, Atsunori Tsuchiya1, Kenya Kamimura1, Yasushi Tamura1, Masato Igarashi1, Hirokazu Kawai1, Satoshi Yamagiwa1, Minoru Nomoto1, Yutaka Aoyagi1.   

Abstract

PURPOSE: To evaluate the value of measuring shear wave velocity evoked by acoustic radiation force impulse (VTTQ) for the risk assessment of hepatocellular carcinoma (HCC) development in patients with nonalcoholic fatty liver disease (NAFLD).
METHODS: VTTQ was measured three times in each of the four liver segments in 163 NAFLD patients, including 14 HCC cases; the results were statistically evaluated.
RESULTS: The VTTQ was 3.04 ± 0.17 m/s (median ± median absolute deviation) and 1.27 ± 0.25 m/s in patients with and without HCC, respectively, and was significantly higher in HCC cases (p < 0.001). When the patients were classified as F0-F4 based on VTTQ cutoff values, VTTQ was significantly higher in the left lobe than in the right lobe for F0 (p < 0.0001) and for F1 and F2 combined (p < 0.0001), but not significantly higher for F3 and F4 combined (p = 0.070). The robust coefficient of variation was significantly higher in the left than in the right (p = 0.018) and significantly increased as VTTQ increased (p = 0.0002). Multivariate analysis showed that total bilirubin concentration {p = 0.014, 38.9 (2.08-727) [odds ratio (95 % confidence interval)]} and VTTQ [p = 0.006, 113 (3.91-3245)] were the only independent explanatory factors for HCC presence among the seven variables identified by univariate analysis. The area under the receiver-operating characteristic curve in the differentiation of HCC from non-HCC was 0.943 for VTTQ and was comparable to that for other noninvasive markers such as Fib-4 (0.964) or higher than that in BARD (0.838).
CONCLUSIONS: These results suggest that fibrosis occurs heterogeneously throughout the liver and that VTTQ measurements are useful in HCC risk evaluation in a NAFLD cohort.

Entities:  

Keywords:  Acoustic radiation force impulse; Hepatocellular carcinoma; Heterogeneity; Liver stiffness; Nonalcoholic fatty liver disease

Year:  2014        PMID: 26202505     DOI: 10.1007/s12072-014-9517-9

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  44 in total

1.  Shear wave elasticity imaging: a new ultrasonic technology of medical diagnostics.

Authors:  A P Sarvazyan; O V Rudenko; S D Swanson; J B Fowlkes; S Y Emelianov
Journal:  Ultrasound Med Biol       Date:  1998-11       Impact factor: 2.998

2.  Liver fibrosis in overweight patients.

Authors:  V Ratziu; P Giral; F Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

Review 3.  Natural history of hepatitis B virus infection: an update for clinicians.

Authors:  Surakit Pungpapong; W Ray Kim; John J Poterucha
Journal:  Mayo Clin Proc       Date:  2007-08       Impact factor: 7.616

4.  Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography.

Authors:  Masato Yoneda; Kaori Suzuki; Shingo Kato; Koji Fujita; Yuichi Nozaki; Kunihiro Hosono; Satoru Saito; Atsushi Nakajima
Journal:  Radiology       Date:  2010-06-07       Impact factor: 11.105

5.  Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging.

Authors:  Diego A Aguirre; Cynthia A Behling; Elliot Alpert; Tarek I Hassanein; Claude B Sirlin
Journal:  Radiology       Date:  2006-05       Impact factor: 11.105

6.  Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography.

Authors:  Ryota Masuzaki; Ryosuke Tateishi; Haruhiko Yoshida; Hideo Yoshida; Shinpei Sato; Naoya Kato; Fumihiko Kanai; Yosuke Sugioka; Hitoshi Ikeda; Shuichiro Shiina; Takao Kawabe; Masao Omata
Journal:  J Clin Gastroenterol       Date:  2008-08       Impact factor: 3.062

7.  Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.

Authors:  Indra Neil Guha; Julie Parkes; Paul Roderick; Dipanker Chattopadhyay; Richard Cross; Scott Harris; Philip Kaye; Alastair D Burt; Steve D Ryder; Guruprasad P Aithal; Christopher P Day; William M Rosenberg
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

8.  Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.

Authors:  Z M Younossi; T Gramlich; Y C Liu; C Matteoni; M Petrelli; J Goldblum; L Rybicki; A J McCullough
Journal:  Mod Pathol       Date:  1998-06       Impact factor: 7.842

9.  Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

Authors:  S A Harrison; D Oliver; H L Arnold; S Gogia; B A Neuschwander-Tetri
Journal:  Gut       Date:  2008-04-04       Impact factor: 23.059

10.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Authors:  Laurent Sandrin; Bertrand Fourquet; Jean-Michel Hasquenoph; Sylvain Yon; Céline Fournier; Frédéric Mal; Christos Christidis; Marianne Ziol; Bruno Poulet; Farad Kazemi; Michel Beaugrand; Robert Palau
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998

View more
  4 in total

Review 1.  Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.

Authors:  Paul Kennedy; Mathilde Wagner; Laurent Castéra; Cheng William Hong; Curtis L Johnson; Claude B Sirlin; Bachir Taouli
Journal:  Radiology       Date:  2018-03       Impact factor: 11.105

2.  Formulation for Effective Screening and Management of Nonalcoholic Steatohepatitis: Noninvasive NAFLD Management Strategy.

Authors:  Kanae Hirose; Tsutomu Kanefuji; Takeshi Suda; Souichi Sugitani; Keisuke Nagasaki; Tomoyuki Kubota; Masato Igarashi; Shuji Terai
Journal:  Gastroenterol Res Pract       Date:  2016-06-13       Impact factor: 2.260

3.  A cut-off value of shear wave speed to distinguish nonalcoholic steatohepatitis candidates.

Authors:  Takeshi Suda; Tsutomu Kanefuji; Atsushi Abe; Itsuo Nagayama; Takahiro Hoshi; Shinichi Morita; Kazuyoshi Yagi; Shigeaki Hatakeyama; Masafumi Hayatsu; Noboru Hasegawa; Shuji Terai
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

Review 4.  Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives.

Authors:  Masayuki Ueno; Haruhiko Takeda; Atsushi Takai; Hiroshi Seno
Journal:  World J Gastroenterol       Date:  2022-07-21       Impact factor: 5.374

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.